National and Kapodistrian University of Athens
Επιδιμιολογικά, κλινικά και ανοσολογικά χαρακτηριστικά της HIV λοίμωξης στους Έλληνες ασθενείς
Abstract
dc:descriptionAcquired Immunodeficiency Syndrome (AIDS) is caused by the human immunodeficiency virus (HTV) which is transmitted by sexual contact, blood and its products and from mother to her fetus or infant. HIV induces collapse of the human immune system with fatal outcome. The brisk sprawling of the HIV pandemic worldwide is accompanied by an explosion in our knowledge on HIV virology, biology, immunology, pathology and treatment of HIV infection and also on the prevention and treatment of opportunistic infections and cancers related to HIV infection.The purpose of this thesis is to evaluate selective immunological, clinical and epidemiological features of HIV infected Greek patients.In the first study, our purpose was to investigate the prevalence of mixed cryoglobulinemia in patients with HIV-1 infection, the clinical spectrum of cryoglobulinemia in these patients, and the possible role of HIV-1 in cryoglobulin formation. This was a prospective cohort study of 89 patients with HIV-1 infection Serum and cryoglobulins were evaluated for antibodies to HIV and hepatitis C virus (HCV), HIV-1, and HCV viral load. Mixed cryoglobulins were detected in 24 patients with HIV-1 infection (27% [95% Cl, 18% to 36%]). The HIV-1 viral load was higher in cryoglobulin-positive patients (median, 38.25 x 103 copies/mL [25th, 75th percentiles: 13.8 x 103 copies/mL, 78.55 x 103 copies/mL]) than in cryoglobulin-negative patients (median, 5.3 x 103 copies/mL [25th, 75th percentiles: 0.7 x 103 copies/mL, 27.2. x 103 copies/mL]) (P = 0.001). Antibodies to HIV were detected in all cryoprecipitates, and HIV-1 RNA sequences were identified in 22 of the 23 cryoprecipitates examined. Nine cryoglobulin-positive patients (38% [Cl, 19% to 54%]) had clinical manifestations compatible with cryoglobulinemia. In conclusion mixed cryoglobulinemia is common in patients with HIV-1 infection.In the second study our objectives were to determine the prevalence of hepatitis viruses B (HBV) and C (HCV) co-infections in HIV-infected patients and the overall impact of these co- infections on deceased AIDS patients survival. One hundred and eighty-one patients (159 males, 22 females) infected with HTV, attending an academic AIDS unit in Athens, Greece, constituted the study population. The study population consisted of 124 homo/bisexual men, 34 heterosexuals, 12 intravenous drug users (IDU) and 11 blood transfusion recipients. Viro logical markers tested for HBV infection included HBsAg, anti-HBs and total anti-HBc by enzyme- linked immunoassays. Detection of HCV antibodies was carried out by third generation enzyme- linked immunoassay, and repeatedly positive samples were further tested by a supplemental enzyme-linked immunoassay; only sera reactive by both methods were considered to be HCV- positive. The prevalence of HBV markers was 67.4%: 71.8% in homo/bisexuals, 35.3% in heterosexuals, 91.7% in IDUs and 90.9% in blood transfusion recipients (P = 0.00004). The prevalence of HCV antibodies was 13.8%: 8.1% in homo/bisexuals, 8.8% in heterosexuals, 58.3% in IDU and 45.5% in blood transfusion recipients (P = 0.000001). The prevalence of HCV antibodies was not significantly higher in homo/bisexuals than in heterosexuals (P = 0.8). Co- infection with HBV or HCV, or both, did not influence the survival of deceased AIDS patients (n = 73). In conclusion, HBV infection was equally prevalent among homo/bisexuals and IDU with HIV infection, whereas HCV infection was more prevalent in IDU than in homo/bisexuals with HIV infection. The prevalence of HCV infection was equal among heterosexuals and homo/bisexuals, indicating that if sexual transmission of HCV occurs, homo/bisexuals are not at greater risk than heterosexuals. Finally, the survival of deceased AIDS patients was not affected by the presence of HBV and HCV co-infections.In the third study, we examined the parameters influencing the survival of AIDS patients who attended our academic unit. The study population consisted of 105 AIDS patients (89 males, 16 females) followed up from September 1986 through August 1996. Of 105 AIDS patients, 66 (62.85%) were deceased. Median survival for all patients was estimated to be 17.9 months. Age at the time of diagnosis, total CD4 cell count at the time of AIDS diagnosis, antiretroviral treatment prior to or after the AIDS diagnosis, year of AIDS diagnosis and sex, were the parameters which significantly related to survival of AIDS patients. In contrast, there was no statistical significance in survival with respect to transmission category, AIDS defining illness and number of initial diagnoses, with one important exception: a single presenting diagnosis of non-Hodgkin lymphoma was associated with higher mortality in bivariable analysis (P < 0.0001). Median survival of deceased patient was 25.5 months, which is similar to the higher median survival reported for AIDS patients.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2003
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Dimitrakopoulos, Antonios
- Δημητρακόπουλος, Αντώνιος
Subjects
dc:subject × 20- Σύνδρομο επίκτητης ανοσολογικής ανεπάρκειας - AIDS
- Ιός ανθρώπινης ανοσοανεπάρκειας
- Κρυοσφαιριναιμία
- Ιός ηπατίτιδας C (HCV)
- Ιός ηπατίτιδας Β (HBV)
- Επιβίωση
- Επιδημιολογία
- Ανοσολογία
- Acquired immune deficiency syndrome
- HIV
- Cryoglobulinemia
- HCV
- HBV
- Survival
- Epidemiology
- Immunology
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/23960